Stay updated on Entinostat Combo in RCC Clinical Trial

Sign up to get notified when there's something new on the Entinostat Combo in RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Entinostat Combo in RCC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study has transitioned to a terminated status, with the funder halting development of the compound for metastatic renal cell carcinoma, while new results have been posted detailing the Phase II study's design and treatment protocols.
    Difference
    23%
    Check dated 2024-09-04T04:45:34.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-08-13T23:15:02.000Z thumbnail image
  5. Check
    32 days ago
    No Change Detected
  6. Check
    47 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, with two locations now included, replacing the previous version v2.9.7.
    Difference
    0.3%
    Check dated 2024-07-23T14:39:07.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T06:23:33.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T14:14:20.000Z thumbnail image
  9. Check
    73 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content related to the study details of a Phase II clinical trial evaluating the safety, pharmacodynamics, and efficacy of Entinostat in combination with Nivolumab and Ipilimumab for patients with metastatic renal cell carcinoma.
    Difference
    0.1%
    Check dated 2024-06-27T10:08:29.000Z thumbnail image

Stay in the know with updates to Entinostat Combo in RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Entinostat Combo in RCC Clinical Trial page.